8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
Quest Diagnostics raises 2026 revenue and EPS guidance after strong third quarter
Filed with the SEC on · Summarized by InvestorsBot
Quest Diagnostics reported third-quarter 2026 revenue of $3.097 billion, up 10.0% from a year earlier, with GAAP diluted EPS of $2.78 and adjusted diluted EPS of $3.00 for the quarter ended September 30, 2026. The company raised its full-year 2026 revenue outlook to $12.065 billion-$12.105 billion, GAAP diluted EPS guidance to $10.21-$10.31, and adjusted diluted EPS guidance to $11.25-$11.35; it also expects approximately $1.90 billion in operating cash flow and $550 million in capital expenditures.